NCT01819311

Brief Summary

This project will test Attention Bias Modification Training (ABMT) among children and adolescents who have completed a full protocol of cognitive behavior therapy (CBT) for anxiety and still meet criteria for a primary diagnosis of an anxiety disorder. The purpose of this project is to determine whether ABMT leads to reductions in anxiety and related impairment, relative to a placebo task condition.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 12, 2013

Completed
15 days until next milestone

First Posted

Study publicly available on registry

March 27, 2013

Completed
5 days until next milestone

Study Start

First participant enrolled

April 1, 2013

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 23, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 23, 2017

Completed
2 months until next milestone

Results Posted

Study results publicly available

August 14, 2017

Completed
Last Updated

October 18, 2017

Status Verified

September 1, 2017

Enrollment Period

4.2 years

First QC Date

March 12, 2013

Results QC Date

July 5, 2017

Last Update Submit

September 20, 2017

Conditions

Outcome Measures

Primary Outcomes (2)

  • Clinician Rating on the Pediatric Anxiety Rating Scale

    The Pediatric Anxiety Rating Scale (PARS) assesses global anxiety severity across social anxiety disorder, separation anxiety disorder, and generalized anxiety disorder in youth ages 6-17 years. An independent evaluator rates anxiety symptoms on 7 dimensions (i.e., number of symptoms, severity of distress, severity of physical symptoms, frequency, avoidance, interference at home, and interference out of home). Each dimension is rated from 0 to 5. Total scores range from 0 to 35, with higher scores indicating greater anxiety severity.

    post-treatment (within one week of completing the final of 8 semi-weekly sessions of Attention Bias Modification)

  • Clinician Rating on the Pediatric Anxiety Rating Scale

    The Pediatric Anxiety Rating Scale (PARS) assesses global anxiety severity across social anxiety disorder, separation anxiety disorder, and generalized anxiety disorder in youth ages 6-17 years. An independent evaluator rates anxiety symptoms on 7 dimensions (i.e., number of symptoms, severity of distress, severity of physical symptoms, frequency, avoidance, interference at home, and interference out of home). Each dimension is rated from 0 to 5. Total scores range from 0 to 35, with higher scores indicating greater anxiety severity.

    8-week follow-up

Secondary Outcomes (4)

  • Screen for Child Anxiety Related Emotional Disorders - Parent Version

    post-treatment (within one week of completing the final of 8 semi-weekly sessions of Attention Bias Modification)

  • Screen for Child Anxiety Related Emotional Disorders - Child Version

    post-treatment (within one week of completing the final of 8 semi-weekly sessions of Attention Bias Modification)

  • Screen for Child Anxiety Related Emotional Disorders - Parent Version

    8-week follow-up

  • Screen for Child Anxiety Related Emotional Disorders - Child Version

    8-week follow-up

Study Arms (2)

Attention Bias Modification

EXPERIMENTAL

Attention Bias Modification is a computer-based attention training program

Behavioral: Attention Bias Modification

Placebo Attention Task

PLACEBO COMPARATOR

The Placebo Attention Task uses the same computer-based format and stimuli as the Attention Bias Modification Task, but does not train attention toward or away from stimuli.

Behavioral: Placebo Attention Task

Interventions

At each of eight sessions, participants complete 160 computer administered trials wherein a pair of threatening stimuli and neutral stimuli is presented simultaneously and then followed immediately by a probe. The probe always replaces the neutral stimulus and never replaces the threatening stimulus. The intervention is based on the idea that attention can be shaped via repetitive computer based training methods, and training attention toward neutral stimuli will lead to a reduction in anxiety and its disorders.

Attention Bias Modification

At each of eight sessions, participants complete 160 computer administered trials wherein a pair of threatening stimuli and neutral stimuli is presented simultaneously and then followed immediately by a probe. The probe replaces the neutral stimulus and the threatening stimulus with equal probability.

Placebo Attention Task

Eligibility Criteria

Age8 Years - 16 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • years old
  • completed a 12-14 week cognitive behavioral therapy for anxiety
  • a primary DSM-IV diagnosis of generalized anxiety disorder, social anxiety disorder, or separation anxiety disorder
  • if other psychiatric disorders are present, they must be treated with medication and stable

You may not qualify if:

  • meet diagnostic criteria for Organic Mental Disorders, Psychotic Disorders, Pervasive Developmental Disorders, or Mental Retardation
  • a high likelihood of harming self or others
  • not been living with a primary caregiver for at least 6 months who is legally able to give consent for the child's participation
  • previously undisclosed abuse requiring investigation or ongoing supervision by the Department of Social Services;
  • involved currently in another psychosocial/behavioral treatment
  • a serious vision problem that is not corrected with prescription lenses
  • a physical disability that interferes with the ability to click a mouse button rapidly and repeatedly

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Florida International University Center for Children and Families

Miami, Florida, 33199, United States

Location

Related Publications (1)

  • Pettit JW, Bechor M, Rey Y, Vasey MW, Abend R, Pine DS, Bar-Haim Y, Jaccard J, Silverman WK. A Randomized Controlled Trial of Attention Bias Modification Treatment in Youth With Treatment-Resistant Anxiety Disorders. J Am Acad Child Adolesc Psychiatry. 2020 Jan;59(1):157-165. doi: 10.1016/j.jaac.2019.02.018. Epub 2019 Mar 13.

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Results Point of Contact

Title
Jeremy W. Pettit (PI)
Organization
Florida International University

Study Officials

  • Jeremy Pettit, PhD

    Florida International University

    PRINCIPAL INVESTIGATOR
  • Wendy Silverman, PhD

    Yale Child Study Centery

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 12, 2013

First Posted

March 27, 2013

Study Start

April 1, 2013

Primary Completion

June 23, 2017

Study Completion

June 23, 2017

Last Updated

October 18, 2017

Results First Posted

August 14, 2017

Record last verified: 2017-09

Locations